POSTMARKING SURVEILLANCE OF ALPRAZOLAM POPULATION PHARMACOKINETICS

被引：0
|
作者：
GRASELA, TH
DEVANE, CL
HILL, M
ANTAL, EJ
机构：
[1] SUNY BUFFALO,SCH PHARM,BUFFALO,NY 14260
[2] UNIV FLORIDA,COLL PHARM,GAINESVILLE,FL 32611
[3] UNIV FLORIDA,COLL MED,GAINESVILLE,FL 32611
[4] NATL JEWISH HOSP & RES CTR,DENVER,CO 80206
[5] UPJOHN CO,PHARMACOKINET PHARMACODYNAM UNIT,KALAMAZOO,MI 49001
来源：
PHARMACOTHERAPY | 1988年 / 8卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：135 / 135
页数：1
相关论文
共 50 条
  • [11] ALPRAZOLAM - PHARMACOKINETICS, CLINICAL EFFICACY, AND MECHANISM OF ACTION
    FAWCETT, JA
    KRAVITZ, HM
    PHARMACOTHERAPY, 1982, 2 (05): : 243 - 253
  • [12] COMPARATIVE PHARMACOKINETICS AND PHARMACODYNAMICS OF LORAZEPAM, ALPRAZOLAM AND DIAZEPAM
    ELLINWOOD, EH
    HEATHERLY, DG
    NIKAIDO, AM
    BJORNSSON, TD
    KILTS, C
    PSYCHOPHARMACOLOGY, 1985, 86 (04) : 392 - 399
  • [13] PHARMACOKINETICS AND PHARMACODYNAMICS OF ALPRAZOLAM AFTER ORAL AND IV ADMINISTRATION
    SMITH, RB
    KROBOTH, PD
    VANDERLUGT, JT
    PHILLIPS, JP
    JUHL, RP
    PSYCHOPHARMACOLOGY, 1984, 84 (04) : 452 - 456
  • [14] INFLUENCE OF MENSTRUAL-CYCLE AND GENDER ON ALPRAZOLAM PHARMACOKINETICS
    KIRKWOOD, C
    MOORE, A
    HAYES, P
    DEVANE, CL
    PELONERO, A
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 50 (04) : 404 - 409
  • [15] Effect of carbamazepine on the single oral dose pharmacokinetics of alprazolam
    Furukori, H
    Otani, K
    Yasui, N
    Kondo, T
    Kaneko, S
    Shimoyama, R
    Ohkubo, T
    Nagasaki, T
    Sugawara, K
    NEUROPSYCHOPHARMACOLOGY, 1998, 18 (05) : 364 - 369
  • [16] Effect of carbamazepine on the single oral dose pharmacokinetics of alprazolam
    Furukori H.
    Otani K.
    Yasui N.
    Kondo T.
    Kaneko S.
    Shimoyama R.
    Ohkubo T.
    Nagasaki T.
    Sugawara K.
    Neuropsychopharmacology, 1998, 18 (5) : 364 - 369
  • [17] PHARMACOKINETICS IN LACTATING WOMEN - PREDICTION OF ALPRAZOLAM TRANSFER INTO MILK
    OO, CY
    KUHN, RJ
    DESAI, N
    WRIGHT, CE
    MCNAMARA, PJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 40 (03) : 231 - 236
  • [18] CLINICAL PHARMACOKINETICS OF ALPRAZOLAM EXTENDED-RELEASE - A SUMMARY
    WRIGHT, CE
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1995, 56 (09): : 947 - 956
  • [19] PHARMACOKINETICS OF ALPRAZOLAM IN GERIATRIC-PATIENTS WITH NEUROTIC DEPRESSION
    DEHLIN, O
    KULLINGSJO, H
    LIDEN, A
    AGRELL, B
    MOSER, G
    OLSEN, I
    PHARMACOLOGY & TOXICOLOGY, 1991, 68 (02): : 121 - 124
  • [20] Alprazolam, caffeine and their interaction: Relating DRL performance to pharmacokinetics
    Lau, CE
    Wang, JH
    PSYCHOPHARMACOLOGY, 1996, 126 (02) : 115 - 124
12345